Within the tumour microenvironment, NY‐ESO‐1, released from necrotic cancer cells, engages with complement C1q receptor and Toll‐like receptor 4 (TLR4) on the surface of immature dendritic cells (DCs). Here, CTAG1B is linked to cancer.